Nucleic acids encoding lymphoid CD30 antigen
US5866372A · kind A · utility
Inventors
Key dates
| Filing date | Sep 8, 1994 |
| Grant date | Feb 2, 1999 |
| Priority date | — |
| Expiry date | Sep 8, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The description relates to the lymphoid surface antigen CD30 (Ki-1) occurring in Hodgkin's disease, the protein sequence and the associated nucleotide sequence therein, manufacture thereof by genetic engineering, methods for diagnosis and investigation of Hodgkin's disease and use of these nucleotide sequences for producing transgenic animals. The invention provides methods not based on monoclonal antibodies for investigation and diagnosis of anaplastic large-cell lymphomas.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.